H

Researcher Profile

H. Rizvi

4

Publications

1,973

Citations

10

Co-Authors

3

Active Years

Publications

Open Access Journal Article Annals of Oncology Aug 01, 2019

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer

K. Hastings · H.A. Yu · W. Wei · F. Sanchez-Vega +27 more

10.1093/annonc/mdz141 312 citations

Open Access Journal Article Annals of Oncology May 01, 2019

Severe immune-related adverse events are common with sequential PD-(L)1 blockade and osimertinib

A.J. Schoenfeld · K.C. Arbour · H. Rizvi · A.N. Iqbal +6 more

10.1093/annonc/mdz077 340 citations

Open Access Journal Article Annals of Oncology Jun 01, 2018

Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer

L. Derosa · M.D. Hellmann · M. Spaziano · D. Halpenny +12 more

10.1093/annonc/mdy103 755 citations

Open Access Journal Article Annals of Oncology Mar 01, 2017

Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer

J.C. Osorio · A. Ni · J.E. Chaft · R. Pollina +10 more

10.1093/annonc/mdw640 566 citations

Publication Timeline

2019

2

2018

1

2017

1

Frequent Co-Authors

A.J. Plodkowski